Early Olezarsen Results Show 50% Reduction in Triglycerides Early Olezarsen Results Show 50% Reduction in Triglycerides

A drug targeting mRNA essential for APO C-III production provided a 50% reduction in triglycerides in BRIDGE-TIMI 73a, the largest ever observed in a controlled trial.Medscape Medical News
Source: Medscape Diabetes Headlines - Category: Endocrinology Tags: Cardiology Source Type: news